Fabio Maria Turazza
YOU?
Author Swipe
View article: Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management Open
The first part of this review highlighted the evolving landscape of atherosclerosis, noting emerging cardiometabolic risk factors, the growing impact of exposomes, and social determinants of health. The prominent role of atherosclerosis in…
View article: Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management Open
The first part of this review highlighted the evolving landscape of atherosclerosis, noting emerging cardiometabolic risk factors, the growing impact of exposomes, and social determinants of health. The prominent role of atherosclerosis in…
View article: Dapagliflozin for the primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy: design of the multi-center phase II randomized PROTECT trial
Dapagliflozin for the primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy: design of the multi-center phase II randomized PROTECT trial Open
Background: Their clinical effectiveness of anthracyclines may be thwarted by the development of cardiotoxicity progressively leading to heart failure (HF) and compromising the quality of life and overall survival of breast cancer (BC) pat…
View article: Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1
Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1 Open
Atherosclerosis, a complex metabolic-immune disease characterized by chronic inflammation driven by the buildup of lipid-rich plaques within arterial walls, has emerged as a pivotal factor in the intricate interplay between cancer and card…
View article: Cardio-oncology rehabilitation: are we ready?
Cardio-oncology rehabilitation: are we ready? Open
Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation but also a pillar of preventive cardio-oncology. Cardio-oncology rehabilitation is a comprehensive model based on a multitargeted approach an…
View article: Atherosclerosis and Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1
Atherosclerosis and Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1 Open
Atherosclerosis, a complex metabolic-immune disease characterized by a chronic inflammation driven by the buildup of lipid-rich plaques within arterial walls, has emerged as a pivotal factor in the intricate interplay between cancer and ca…
View article: Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer
Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer Open
Atrial fibrillation (AF) is an increasingly recognized comorbidity in patients with cancer. Indeed, cancer patients have a significantly higher incidence of AF than that observed in the general population. A reciprocal relationship between…
View article: Causes of death in women with breast cancer: a risks and rates study on a population-based cohort
Causes of death in women with breast cancer: a risks and rates study on a population-based cohort Open
Introduction The increasing survival of patients with breast cancer has prompted the assessment of mortality due to all causes of death in these patients. We estimated the absolute risks of death from different causes, useful for health-ca…
View article: Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals Open
[This corrects the article DOI: 10.3389/fcvm.2023.1223660.].
View article: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals Open
In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patien…
View article: Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer
Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer Open
Atrial fibrillation (AF) is an increasingly recognized comorbidity in patients with can-cer. Indeed, cancer patients have a significantly higher incidence of AF than that ob-served in the general population. A reciprocal relationship betwe…
View article: P420 A CANCER PATIENT WITH PULMONARY THROMBOEMBOLISM: IS IT RIGHT TO APPLY THE CRITERIA FOR DOSE REDUCTION IN THESE PATIENTS?
P420 A CANCER PATIENT WITH PULMONARY THROMBOEMBOLISM: IS IT RIGHT TO APPLY THE CRITERIA FOR DOSE REDUCTION IN THESE PATIENTS? Open
A 78 years old woman presented in our cardio–oncology out–patient clinic to renew apixaban treatment plan. In her medical history she was a former smoker, with a chronic kidney disease in IIIb stadium according to KDIGOI guidelines with a …
View article: P173 THERAPEUTIC MANAGEMENT OF FLUOROPYRIMIDINE CARDIOTOXICITY: AN ANECDOTAL CASE
P173 THERAPEUTIC MANAGEMENT OF FLUOROPYRIMIDINE CARDIOTOXICITY: AN ANECDOTAL CASE Open
Background Fluoropirimidine represents one of the staple treatment of metastatic colorectal cancer; chemoterapy–based cardiotoxicity is unfortunately habitual in clinical practice. Raltitrexed could represent a valid alterantive to 5–FU in…
View article: P424 MEDIASTINAL ROUND CELL SARCOMA WITH PULMONARY ARTERY STENOSIS: CLINICAL USEFULNESS OF CARDIAC MRI IN CARDIO–ONCOLOGY
P424 MEDIASTINAL ROUND CELL SARCOMA WITH PULMONARY ARTERY STENOSIS: CLINICAL USEFULNESS OF CARDIAC MRI IN CARDIO–ONCOLOGY Open
Case description: a previously healthy 26–year–old man presented with dyspnea on exertion and dry cough. CT scan revealed a large mediastinal mass with displacement of great vessels and trachea and pericardial effusion. Cardiac MRI showed …
View article: P126 RADIOTHERAPY AND THE HEART: IN SEARCH OF ARIANNA‘S THREAD
P126 RADIOTHERAPY AND THE HEART: IN SEARCH OF ARIANNA‘S THREAD Open
Background Radiation therapy (RT) is widely diffused in the treatment of cancer; but it could lead to various negative consequences on the cardiovascular system, even several years after treatment end. They include also valvular heart dise…
View article: C33 AN UNEXPECTED CARDIOGENIC SHOCK
C33 AN UNEXPECTED CARDIOGENIC SHOCK Open
Background Chemotherapy regime based on 5–fluorouracil (5–FU) are frequently administered in the treatment of gastro–intestinal malignancies, especially colorectal carcinomas. A potential severe side effect of 5–FU is cardiotoxicity with o…
View article: Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story
Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story Open
[This corrects the article DOI: 10.3389/fcvm.2022.821193.].
View article: Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab
Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab Open
In anthracycline-exposed patients with early breast cancer, hs-TnT may be able to identify those at risk of developing cardiac toxicity during neo/adjuvant T treatment.
View article: Women at heart: Introducing gender cardio-oncology
Women at heart: Introducing gender cardio-oncology Open
As cardio-oncology imposed itself as the reference specialty for a comprehensive cardiovascular approach to all patients with cancer, a more specific and careful cardiac evaluation of women entering their journey into cancer care is needed…
View article: Baseline characteristics of patients with atrial fibrillation and cancer enrolled in the BLITZ-AF Cancer registry
Baseline characteristics of patients with atrial fibrillation and cancer enrolled in the BLITZ-AF Cancer registry Open
Background Evidences on atrial fibrillation (AF) in patients with cancer are limited, specifically with respect to antithrombotic therapy. Methods BLITZ-AF Cancer is a prospective, non-interventional study of the epidemiology and managemen…
View article: Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story Open
[This corrects the article DOI: 10.3389/fcvm.2022.821193.].
View article: C67A BLITZ-AF CANCER REGISTRY: BASELINE CHARACTERISTICS OF PATIENTS WITH ATRIAL FIBRILLATION AND CANCER
C67A BLITZ-AF CANCER REGISTRY: BASELINE CHARACTERISTICS OF PATIENTS WITH ATRIAL FIBRILLATION AND CANCER Open
Background Evidences on atrial fibrillation (AF) in patients with cancer are limited, specifically with respect to antithrombotic therapy. Methods BLITZ-AF Cancer is a prospective, non-interventional study of the epidemiology and managemen…
View article: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story Open
The pathophysiology of some non-communicable diseases (NCDs) such as hypertension, cardiovascular disease (CVD), diabetes, and cancer includes an alteration of the endothelial function. COVID-19 is a pulmonary and vascular disease with a n…
View article: Cardiologic Long-Term Follow-Up of Patients Treated With Chest Radiotherapy: When and How?
Cardiologic Long-Term Follow-Up of Patients Treated With Chest Radiotherapy: When and How? Open
Introduction: Radiotherapy may cause valvular (VHD), pericardial, coronary artery disease (CAD), left ventricular dysfunction (LVD), arrhythmias. The risk of radiation induced heart disease (RIHD) increases over time. The current guideline…
View article: ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO) Open
The COVID-19 pandemic and its impact on patients with cancer and cardiovascular disease have confirmed the particular vulnerability of these populations. Indeed, not only a higher risk of contracting the infection has been reported but als…
View article: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey Open
Aims: Cardio-oncology has achieved a pivotal role in science, but real world data on its clinical impact are still limited. Methods: A questionnaire was sent out to all cardio-oncology services across Italy ( n = 120). The questionnaire wa…
View article: Reproducibility of in‐hospital worsening heart failure event adjudication in the RELAX‐AHF‐EU trial
Reproducibility of in‐hospital worsening heart failure event adjudication in the RELAX‐AHF‐EU trial Open
In-hospital worsening heart failure (WHF) is a commonly employed endpoint in acute heart failure (AHF) trials that implies deterioration of the signs and/or symptoms of AHF that require treatment adaptation. Some recent AHF trials have est…
View article: Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial Open
Background The independent prognostic impact of diabetes mellitus ( DM ) and prediabetes mellitus (pre‐ DM ) on survival outcomes in patients with chronic heart failure has been investigated in observational registries and randomized, clin…